Can patients with chronic liver disease take sodium fructose diphosphate tablets long-term?

Patients with chronic liver disease generally have stable liver function and long-term medication needs, so they can usually take sodium fructose diphosphate tablets for a long time. If the condition is unstable and liver function is severely impaired, long-term use of this medication is typically not recommended. It is advisable to seek timely medical attention, identify the underlying cause, and undergo symptomatic treatment under the guidance of a qualified physician.

Sodium fructose diphosphate tablets can effectively activate pyruvate kinase activity and reduce liver cell damage. For patients with chronic liver disease, if no adverse symptoms occur during medication, long-term use of this drug may be considered. This is because sodium fructose diphosphate tablets help promote the recovery of damaged liver cells and play a certain role in facilitating tissue cell repair.

If a patient has already developed severe liver insufficiency, such as in the late stages of cirrhosis or hepatic encephalopathy, long-term use of sodium fructose diphosphate tablets may increase the burden on the liver and thus be detrimental. Long-term medication may cause side effects; for sodium fructose diphosphate tablets, this could include gastrointestinal discomfort and, in severe cases, necessitate discontinuation of the drug. Patients with chronic liver disease taking sodium fructose diphosphate tablets should undergo regular related examinations, such as liver function tests and electrolyte level assessments, to monitor the drug's efficacy and any adverse reactions.

In addition to pharmacological treatment, patients with chronic liver disease should also focus on adjusting their lifestyle, such as maintaining a balanced diet, controlling body weight, and limiting alcohol consumption, to promote disease recovery.